PTH and hyperphosphatemia: Since PTH inhibits phosphate reabsorption and induces 25-dihydroxy vitamin D 1-α-hydroxylase (Cyp27b1) mRNA expression through the cAMP-dependent cellular mechanism, patients may develop not only hyperphosphatemia but also hypocalcemia.